Search research articles
Contact Us
Filters
Showing results (21-30 of 54) with videos related to
Page
of 6
Sort By:
American Heart Journal
|
August 5, 2000
Effect of sex, hemodynamics, body size, and other clinical variables on the corrected thrombolysis in myocardial infarction frame count used as an assessment of coronary blood flow
B A Faile, J A Guzzo, D A Tate, et al.
Thrombosis and Haemostasis
|
August 26, 2000
Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill colony
R W Herzog, V R Arruda, T H Fisher, et al.
Mayo Clinic Proceedings
|
July 1, 1991
von Willebrand factor and animal models: contributions to gene therapy, thrombotic thrombocytopenic purpura, and coronary artery thrombosis
K M Brinkhous, R L Reddick, M S Read, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 21, 2011
Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII (N8) in haemophilia A dogs
D M Karpf, M Kjalke, L Thim, et al.
Circulation Research
|
November 26, 1999
Reduction in atherosclerotic lesion size in pigs by alphaVbeta3 inhibitors is associated with inhibition of insulin-like growth factor-I-mediated signaling
T C Nichols, T du Laney, B Zheng, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 8, 2011
Pharmacokinetics, pharmacodynamics and safety of recombinant canine FVIIa in a study dosing one haemophilia A and one haemostatically normal dog
T Knudsen, A T Kristensen, T C Nichols, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 7, 2012
Sensitivity of whole blood clotting time and activated partial thromboplastin time for factor IX: relevance to gene therapy and determination of post-transfusion elimination time of canine factor IX in hemophilia B dogs
T C Nichols, H W G Franck, C T Franck, et al.
Thrombosis and Haemostasis
|
June 1, 2002
Pharmacokinetics of recombinant factor IX after intravenous and subcutaneous administration in dogs and cynomolgus monkeys
K McCarthy, P Stewart, J Sigman, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
April 1, 1993
Occlusive arterial thrombosis in cynomolgus monkeys with varying plasma concentrations of lipoprotein(a)
J K Williams, D A Bellinger, T C Nichols, et al.
Antisense & Nucleic Acid Drug Development
|
January 26, 1999
Failure to achieve gene conversion with chimeric circular oligonucleotides: potentially misleading PCR artifacts observed
Z Zhang, M Eriksson, G Falk, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 54) with videos related to
Sort By:
Page
of 6
American Heart Journal
|
August 5, 2000
Effect of sex, hemodynamics, body size, and other clinical variables on the corrected thrombolysis in myocardial infarction frame count used as an assessment of coronary blood flow
B A Faile, J A Guzzo, D A Tate, et al.
Thrombosis and Haemostasis
|
August 26, 2000
Absence of circulating factor IX antigen in hemophilia B dogs of the UNC-Chapel Hill colony
R W Herzog, V R Arruda, T H Fisher, et al.
Mayo Clinic Proceedings
|
July 1, 1991
von Willebrand factor and animal models: contributions to gene therapy, thrombotic thrombocytopenic purpura, and coronary artery thrombosis
K M Brinkhous, R L Reddick, M S Read, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 21, 2011
Pharmacokinetics and ex vivo whole blood clot formation of a new recombinant FVIII (N8) in haemophilia A dogs
D M Karpf, M Kjalke, L Thim, et al.
Circulation Research
|
November 26, 1999
Reduction in atherosclerotic lesion size in pigs by alphaVbeta3 inhibitors is associated with inhibition of insulin-like growth factor-I-mediated signaling
T C Nichols, T du Laney, B Zheng, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
June 8, 2011
Pharmacokinetics, pharmacodynamics and safety of recombinant canine FVIIa in a study dosing one haemophilia A and one haemostatically normal dog
T Knudsen, A T Kristensen, T C Nichols, et al.
Journal of Thrombosis and Haemostasis : JTH
|
April 7, 2012
Sensitivity of whole blood clotting time and activated partial thromboplastin time for factor IX: relevance to gene therapy and determination of post-transfusion elimination time of canine factor IX in hemophilia B dogs
T C Nichols, H W G Franck, C T Franck, et al.
Thrombosis and Haemostasis
|
June 1, 2002
Pharmacokinetics of recombinant factor IX after intravenous and subcutaneous administration in dogs and cynomolgus monkeys
K McCarthy, P Stewart, J Sigman, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology
|
April 1, 1993
Occlusive arterial thrombosis in cynomolgus monkeys with varying plasma concentrations of lipoprotein(a)
J K Williams, D A Bellinger, T C Nichols, et al.
Antisense & Nucleic Acid Drug Development
|
January 26, 1999
Failure to achieve gene conversion with chimeric circular oligonucleotides: potentially misleading PCR artifacts observed
Z Zhang, M Eriksson, G Falk, et al.
Page
of 6